Mass spectrometry profiling of 5812 proteins across 28 healthy postmenopausal ovaries (ages 50–75) documents progressive, age-stratified molecular change rather than biological silence. Protein signatures shift from RNA and gene-regulatory functions in the sixth decade toward metabolic, trafficking, and innate immune and complement pathways by age 70 and beyond, accompanied by extracellular matrix remodeling, inflammatory signaling, and loss of structural proteins. A 26-protein consensus signature, with WNT4 and fibromodulin confirmed by immunohistochemistry, provides a measurable readout of this trajectory.
Key Points
- Postmenopausal ovary remains metabolically and immunologically active for decades
- 117 proteins shifted significantly between ages 50–59 and 70+
- 26-protein signature tracks matrix remodeling and inflammatory secretory output
Longevity Analysis
An organ long treated as functionally retired continues to secrete matrix and inflammatory factors into the pelvic and systemic environment, making it a potential contributor to the low-grade inflammatory load that accumulates with age rather than a bystander to it. The drift from gene-regulatory toward complement and innate immune pathways mirrors patterns seen in other aging tissues, where the balance between repair capacity and chronic immune activation determines functional reserve. Measurable protein signatures of this kind move post-reproductive ovarian status from an assumed endpoint to a trackable variable, with implications for how hormonal transitions, inflammatory burden, and tissue maintenance are monitored in women over fifty.
Original published by Wiley Aging Cell, by Mark A. Watson, Bikem Soygur, Christina D. King, Pooja R. Devrukhkar, Simon Melov, Elisheva D. Shanes, Mary Ellen G. Pavone, Francesca E. Duncan, Birgit Schilling .